Is Ertaczo in shortage in 2026? Get the latest update on Sertaconazole cream availability, pricing, and what patients can do right now.
If you've been trying to fill an Ertaczo (Sertaconazole Nitrate) prescription and keep hitting dead ends, you're probably wondering if there's an official shortage. The short answer is complicated — and that's exactly why we wrote this update.
In this article, we'll cover the current status of Ertaczo availability, what's driving the supply challenges, how much it costs in 2026, and what you can do to get your prescription filled.
As of early 2026, Ertaczo is not listed on the FDA or ASHP official drug shortage databases. That means there isn't a formal, declared shortage of Sertaconazole Nitrate cream in the United States.
However, that doesn't tell the full story. Many patients report difficulty finding Ertaczo at their local pharmacies. The medication is frequently out of stock at major chains like CVS, Walgreens, and Rite Aid. This "practical shortage" — where the drug technically exists but is hard to get — is a common frustration for patients who rely on brand-only medications with limited distribution.
So while the FDA hasn't flagged it, the reality on the ground is that Ertaczo can be very hard to find. For tips on locating it, see our guide on how to find Ertaczo in stock.
Several factors contribute to Ertaczo's limited availability:
Ertaczo is manufactured by DPT Laboratories and distributed by Coral Way Pharma, LLC. There is no generic version of Sertaconazole available in the United States. When only one company makes a drug, any production hiccup, quality control issue, or supply chain delay can ripple through the entire market.
With a retail price of $897 to $1,070 per tube, Ertaczo represents a significant inventory investment for pharmacies. Many choose not to stock it unless they have a confirmed prescription waiting, because unsold tubes tie up hundreds of dollars on the shelf. This creates a chicken-and-egg problem: patients can't find it because pharmacies don't stock it, and pharmacies don't stock it because patients can't afford it.
Most insurance plans require patients to try cheaper antifungals first — like over-the-counter Clotrimazole (Lotrimin) or Terbinafine (Lamisil) — before they'll approve coverage for Ertaczo. This step therapy requirement means fewer patients actually fill Ertaczo prescriptions, further reducing demand and incentive for pharmacies to carry it.
Ertaczo is FDA-approved specifically for interdigital tinea pedis (athlete's foot between the toes). While doctors sometimes prescribe it off-label for ringworm, jock itch, and other fungal infections, its narrow official indication means it serves a smaller patient population than broad-spectrum antifungals.
Here's a breakdown of current pricing:
For a comprehensive look at ways to reduce your costs, read our guide to saving money on Ertaczo.
As of early 2026, there is still no generic Sertaconazole available in the United States. No new generic applications have been publicly announced.
However, patients do have access to several alternative antifungals that treat the same conditions:
For detailed comparisons, see our full article on alternatives to Ertaczo.
If you still need Ertaczo specifically, here's your game plan:
Use Medfinder to see which pharmacies near you currently have Ertaczo in stock. It checks availability in real time so you don't waste time calling around.
Independent pharmacies are often better at sourcing niche medications. They may be able to order Ertaczo through their wholesaler even if it's not on the shelf.
Most pharmacies can special-order Ertaczo in 1-3 business days. Ask your pharmacist to check with their wholesaler and confirm availability before placing the order.
Specialty mail-order pharmacies sometimes have better access to brand-name medications. Check with your insurance plan to see if mail-order is an option.
If cost is a barrier, discount cards can make a meaningful difference. A SaveHealth card can bring the price down to around $447 — still not cheap, but nearly half the retail price.
Ertaczo isn't in an official FDA shortage in 2026, but that doesn't make it any easier to find. The combination of single-source manufacturing, no generic competition, high cost, and insurance barriers creates real access challenges for patients who need this medication.
Your best tools are Medfinder for checking stock, discount cards for reducing costs, and an open conversation with your doctor about whether an alternative antifungal might work just as well. For more details on what Ertaczo is and how to use it, check out our comprehensive guide.
Stay informed, plan ahead, and don't hesitate to advocate for yourself at the pharmacy counter. You have more options than you might think.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
